A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Bioinformatics Core (BIC) Facility

Bioinformatics Core (BIC) Facility
City of Hope’s Bioinformatics Core (BIC) Facility provides researchers with high-throughput biological data analysis tools, data management, unified cyber-infrastructure, training, as well as trained staff working with multidisciplinary team to facilitate experimental design, information management, data integration, annotation, dissemination and visualization. Our goal is to foster collaborations and provide high-performance parallel computational support for principle investigators and develop modern computational techniques and methodologies for their basic and translational research.

The facilities and their services are available to both City of Hope and non-City of Hope researchers to include in their grant proposals for adequate chargeback.
The Bioinformatics Core Facility provides support in the following areas:
  1. Image Analysis Resources: The BIC provides data analysis and data management support for both the Sequencing Core and individual researchers for Illumina Solexa and Roche/454 as well as for sequence data generated from ABI sequencers.
  2. Microarray Analysis: The BIC provides statistical analysis and biological interpretation for microarray data as well as data integration for various array types.  BIC is also building a microarray database from open-source gene expression data. 
  3. Computer-Assisted Molecular Design Resources: The BIC conducts computer-assisted molecular design analysis, performs 3D structure analysis of protein/DNA/RNA and their drug complexes, and provides large compound libraries and similarity queries for drug discovery.
  4. Molecular Imaging Analysis: The BIC plans to expand services offered to cover imaging analysis (e.g. microscopy analysis, quantification of reporter genes, etc.).
  5. LIMS: The BIC offers Laboratory Information Management Systems (LIMS) for Next-Generation-Sequencing (CBIS), Microarray (caArray), and High-Throughput Screening (CBIS) data.
  6. Software Support: The BIC encourages users to conduct their own analysis, and provides useful software via Citrix and local installation on BIC workstations.  Training sessions are offered for available software and post tutorials/FAQs are posted on the BIC wiki.  BIC also designs high performance cyber-infrastructure and analysis pipelines to automate the collections of experimental information.
  7. Ad hoc Software Development: The BIC develops new tools for users (such as the ArrayTools R package, SeqGene analysis software, the Similarity Search Pipeline, and the siRNA Site Selector).
Please contact Yate-Ching Yuan - yyuan@coh.org - for any questions, help requests, feedback, or ad hoc support.

Research reported in this publication included work performed in the Bioinformatics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Genomic Analysis Resources

  • Analyze data provided by the Functional Genomics Core
  • Develop semi-automated analysis pipelines in order to provide more efficient support.
  • Build a database of open source microarray data that will allow users to analyze associations between genes and clinical variables (stage, age, survival, etc.)
  • Provide consultation, interpretation, and visualization of analysis results
  • Create laboratory information management systems (LIMS) for sample and experiment inventory as well as automated data pre-processing pipelines.
  • Provide software (such as Partek, IPA, etc.) to assist users with their own analysis
The following types of microarray analysis are currently supported:
  1. Gene Expression Profiling
  2. miRNA Profiling
  3. DNA Methylation Array Analysis
  4. Exon Splicing Array Analysis
  5. Tiling Array Analysis - Includes ChIP-ChIP
  6. CGH Array Analysis (Copy Number Analysis)
  7. Drug Metabolism Analysis (DMET array)
  8. Pathway analysis and functional interpretation

Image Analysis Resources

  • Perform QC for data collected at the Sequencing Core.
  • Provide support for data pre-processing, including adapter trimming, bar code trimming, sequence alignment and data format conversion so that the Solexa user can easily visualize NGS sequencing data using IGV and other software.
  • Develop semi-automated Solexa analysis pipelines to provide more efficient support.
  • Provide consultation, interpretation, and visualization of analysis results.
  • Create laboratory information management systems (LIMS) for sample and experiment inventory as well as automated data pre-processing pipelines.
  • Provide software (such as Partek, NextGENe, etc.) to assist users with their own analysis.
The following types of sequence analysis are currently supported:
  1. mall RNA-seq, including expression level of small RNAs (including miRNA and other non-coding RNAs), detection of novel small RNAs, prediction of novel miRNA precursors and differential expression analysis.
  2. DNA-Seq, mainly for copy number analysis.
  3. Targeted resequencing (e.g. exome sequencing, PCR amplicon sequencing), including variants detection, small and large indel detection, and structural variation.
  4. RNA-seq, including peak detection, motif analysis, and more advanced analysis.
  5. ChIP-seq, including peak detection, motif analysis, and more advanced analysis
  6. For other data types, consult the BIC staff.

Computer-Assisted Molecular Design Resources

  • Structural/functional analysis for disease related biological process
  • Computer-aided therapeutic discovery and development
  • Provide the High-Throughput Screening Core with data analysis and data management assistance.
  • Provide consultation, interpretation, and visualization of analysis results
  • Develop novel tools for analysis
  • Create laboratory information management systems (LIMS) for sample and experiment inventory as well as automated data pre-processing pipelines
  • Provide software (such as PyMol, NAMD, etc.) to assist users with their own analysis
The following types of drug-discovery initiatives are currently supported:
  1. Biomarker Analysis: An in depth understanding and analysis of the biological functions and 3D structural relationships of therapeutic targets (protein, small RNA, organic compounds) are essential for understanding the molecular mechanisms and binding modes of these tertiary complex interactions. Virtual screening can be performed on the 3D structure and binding sites based on the X-ray structure and/or predicted homology model.  Ligand-based virtual screening can be performed by 2D and/or 3D tools (developed in house) as well as the compounds library database to find analogues among more than 15 million drug-like compounds.
  2. Chemical Library Preparation: The drug candidates are screened from a collection of chemical libraries that the BIC core has collected.  Millions of compounds from various commercial and public libraries have been integrated.  The BIC core also filters HTS results based on HTS and ADMET requirements to help reduce the redundancy, as well as false positive and false negative hits.
  3. Lead Identification: Structure-based or ligand-based virtual screening is conducted, as well as 2D/3D structure similarity compound searches among several million candidates from the NCI DTP, UCSF ZINC, NCBI Pubmed and COH HTS compound libraries.
  4. Lead Optimization: The lead compounds are further optimized by computational chemistry methods such as Molecular Dynamic Simulation and QSAR analysis.
  5. Pre-clinical Trial: The drug candidates obtained from the virtual screenings are readied by the investigator for pre-clinical trials.  The experimental results are then fed back through the drug-design process for drug refinement.

Software / Equipment

BIC Software (on Citrix)
  • Programs for Image Analysis: Biobase TRANSFAC, CLC Bio Genomics Workbench, CLC Bio Main Workbench, DMET Console, IGV, Labshare, NextGene, Oligo, R, Seqlab, Sequence Alignment, Sequencer, SeqWeb 3, Vector NTI (Version 10 and 11)
  • Genomic Analysis:  Ingenuity Pathway Analysis, Biobase TRANSFAC, Cluster 3.0, GeneSpring 7.3, GeneSpring GX, IGV, ImaGene, Matlab, Oligo, Partek, R, Signal Map
  • Computer-Assisted Molecular Design: Cn3D, COH Similarity Pipeline, Discovery Studio, DS Viewer Pro, HyperChem 7.5, Matlab, Pymol, R, Rasmol, Swiss PDB Viewer
  • DCT: CBIS, Biocore T100 Evaluation, Chem4D Draw, and HyperChem 7.5 DCT
  • A limited number of programs are not available on Citrix: contact Yate-Ching Yuan, Ph.D. at yyuan@coh.org for more details
BIC Workstations
  • Commonly used bioinformatics programs are also installed on 9 BIC workstations located in computer rooms throughout the campus and in the Flower building.  Contact Yate-Ching Yuan, Ph.D. at yyuan@coh.org for the locations and policies of BIC workstations.
Computational Resources
  • scaleMP - Cyberinfrastructure utilizes the latest blade system technology and ScaleMP's Versatile SMP (vSMP) Foundation technology to deliver a scalable computation solution. The computational resources of the Cyberinfrastructure compose a scaleMP vSMP system with 32 core and 128GB memory, high performance database servers, and high performance MS Windows/Linux application servers.
  • Isilon Tired Storage Cluster solutions – 143 TB of data for storing results from high-throughput sequencing, high-throughput screening, and microarray results.
  • A large number of different servers are utilized to meet users’ needs. Contact Yate-Ching Yuan, Ph.D. at yyuan@coh.org for details.

Bioinformatics Core (BIC) Facility Using the Facility

Image Analysis Resources
  • Contact Harry Gao from the DNA Sequencing/Solexa Core and Xiwei Wu or Xutao Deng from the BIC to ensure optimal experimental design.
  • When the DNA Sequencing/Solexa Core completes a sequencing run the data will be directly piped to the BIC staff unless instructed otherwise.
  • The turn-around time will vary depending on the complexity of the project. The turn-around time for most applications is 2-3 weeks. For novel applications, the turn-around time may be up to 3-4 weeks.
  • The BIC does not typically support analyzing public domain sequencing data.
  • Contact Haiqing Li if support is needed on LIMS, database, software or hardware issues related to sequencing.

Genomic Analysis Resources
  • The BIC analyzes microarray data produced by the Functional Genomics Core. The turn-around time (after receiving the raw data from the Functional Genomics Core) is typically 2-3 weeks.
  • The BIC also provides some data mining of publicly available datasets on a case-by-case basis.  Contact Yate-Ching Yuan (yyuan@coh.org) for more information.

Computer-Assisted Molecular Design Resources
Contact Yate-Ching Yuan to set up a project planning meeting for the purpose of assembling team collaborations from other Cores as needed.

Abstract for Grants

City of Hope’s Bioinformatics Core (BIC) facility provides researchers with high-throughput biological data analysis tools, data management, unified cyber-infrastructure, training, as well as trained staff working within  multidisciplinary teams to facilitate experimental design, information management, data integration, annotation, dissemination and visualization. Our goal is to foster collaborations and provide high-performance parallel computational support for principle investigators and develop modern computational techniques and methods for their basic and translational research.
Image Analysis Resources
BIC will support CPU/memory intensive parallel computation for Smith-Waterman alignment algorithm on GPU using CUDA sequence alignment, BLAST/BLAT/BioMart database search, MEM motif prediction, MFOLD RNA folding, and sequence contig assembly analysis etc. Invitrogen Labshare Oracle based data management is provided for Vector NTI sequence analysis, MacVector, GeneCode Sequencher, CLC Bio Workbench, TRANSFAC gene transcription factor database, as well as open source NCBI BLAST, BLAT services, Oligo design, UCSC local mirror site with human and mouse database, Broad IGV, and Mathwork Matlab statistical and bioinformatics tool kits.
BIC will support statistical and computational analysis for image preprocessing, base calling, sequence alignment, and down-stream analysis of DNA-Seq, ChIP-seq, Methyl-seq, mRNA-seq, smRNA-seq, targeted resequencing, RNA-seq.  BIC currently hosts commercial Illumina Solexa GA II pipeline and CASAVA, Roche 454 , vendor based NGS analysis software from SoftGenetics NextGENe, and Partek Genomics Suite, as well as several academic open source software products such as local mirror site of UCSC Genome browser, Blat, SOAP, MAQ, BWA, Bowtie, Novoalign, Samtools, R/Bioconductor, LIMS such as SeqWare and CBIS. BIC also developed accelerated Smith-Waterman alignment algorithm on GPU using CUDA for supporting efficient Solexa genome-wide alignment which will accommodate large indels and abundant structural variations, as well as SeqGene for Exome and transcritomic open source NGS analysis. BIC also provides training workshops for Partek, NextGENe, NCBI, Ensemble, BioMart, UCSC genome browser, and Broad IGV etc.
Genomic Analysis Resources
BIC will support statistical and computational programs for microarray image preprocessing, generating differential expression profiling for biomarkers, down-stream analysis for expression, copy number, miRNA, ChIP-ChIP analysis, as well as integrated genomic analysis. BIC currently hosts comprehensive commercial microarray software from Affymetrix, Agilent, NimbleGen, Exiqon, BioDiscovery, Nexus, Partek Genomics Suite, Agilent GeneSpring, Ingenuity as well as many academic open source software such as local mirror site of UCSC Genome browser, Blat, Biobase TRANSFAC, Gene Cluster, and R/Bioconductor, etc. We also provide user training workshops for Partek, GeneSpring, NCBI, Ensemble, BioMart, and UCSC genome browser etc.
Computer-Assisted Molecular Design Resources
BIC can provide a structure based virtual ligand screening (VLS) approach to identify potential leads against the X-ray crystal structure and/or homology models of potential ligand binding sites that were predicted. BIC can provide the qualitative assessment for virtual mutagenesis experiments to predict the structural activity relationships and then compare with bioassay results. BIC offers molecular dynamic simulation of these protein-ligand complex structures as well as their association constants as confirmation of the docking strategy. BIC can also design a highly diverse HTS compound library available for robotic screening based on approximately 15 million compounds downloaded from NCBI PubChem, as well as  several thousand natural compound libraries. BIC can correlate binding affinity and IC50 of potential ligands to perform CoMFA and QSAR analysis to assist medicinal chemistry to optimize potential leads. BIC can also perform ADMET analysis for the prediction of toxicity and metabolomic predictions to develop drugable compounds for clinical trials. BIC currently hosts comprehensive commercial modeling software from Tripos, Schrodinger, SimulationPlus, Chemiinovation, academic software AMBER, Charmm, MOPAC, as well as compound libraries from NCBI, UCSF ZINC, and several pharmaceutical companies such as Chambridge, ChemDiv, etc. User training workshops are conducted for NCBI, TRIPOS, Schrodinger, Ensemble.

Bioinformatics Core Team

Contact Us

Yate-Ching Yuan, Ph.D.
Associate Research Professor
Bioinformatics Core Facility
626-256-HOPE (4673)
ext. 62161

Xiwei Wu, Ph.D.
Assistant Research Professor
Associate Director,
Bioinformatics Core Facility
626-256-HOPE (4673)
ext. 65071

Zheng Liu, Ph.D.
Assistant Research Professor
Bioinformatics Core Facility
626-256-HOPE (4673)
ext. 65170

Hongzhi Li, Ph.D.
Assistant Research Professor
626-256-HOPE (4673)

Leila Su, Ph.D.
Assistant Research Professor
626-256-HOPE (4673)
ext. 63753

Haiqing Li, Ph.D.
Staff Scientist
626-256-HOPE (4673)
ext. 63653

Charles Warden, M.A.
626-256-HOPE (4673)
ext. 60233

Bing Mu, M.S.
Bioinformatics Specialist
626-256-HOPE (4673)
ext. 60553

Sue Hargrave, B.A.
Project Coordinator
626-256-HOPE (4673)
ext. 64275


Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti


For sponsorships inquiries please contact:

Stefanie Sprester

Christine Nassr

Facebook  Twitter  YouTube  Blog
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...
  • New pelvic exam recommendations or not, women shouldn’t give up those routine gynecological appointments. The revised guidelines from the American College of Physicians exempt most women from pelvic examinations, but a cancer specialist at City of Hope says women should still plan on regular visits with t...